An Open-label, Dose-finding, Phase I Study to Evaluate the Safety and Immunogenicity of a Bivalent Klebsiella Pneumoniae Vaccine (CHO-V08) in Healthy Adults

NCT07016152 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Klebsiella Pneumoniae Infection
Vaccine

Interventions

BIOLOGICAL: Glyconjugate Klebsiella pneumoniae bivalent vaccine

Sponsor

Cho Pharma Inc.